"I love Home - Landing Page - Vaxcyte"

2022-05-16 18:09:22

Skip to main content Close Search search Menu About UsCorporate ProfileManagement TeamBoard of DirectorsScientific Advisory BoardOur PlatformOur ProgramsConjugate VaccinesLead Program: PCVPipelinePosters / PublicationsInvestors & MediaOverviewPress ReleasesEvents & PresentationsCorporate GovernanceGovernance OverviewBoard of DirectorsManagementCommittee CompositionFinancials & FilingsStock InformationStock Quote & ChartHistoric Price LookupAnalyst CoverageInvestor ResourcesInvestor FAQsEmail AlertsIR ContactTax DisclosuresCareersContactsearch We are on a global missionto engineer high-fidelity vaccines that protect humankind from the consequences of bacterial diseases. PlatformExclusive license to XpressCF™, an industrialized cell-free protein synthesis platform, for the vaccine field allowing: (1) site-specific conjugation; (2) production of complex antigens in more optimal conformation; and (3) speed, flexibility and scalability of the discovery engine. PeopleAssemblage of preeminent vaccinologists, vaccine developers & biotech company-builders joined together to harness the platform to create positive synergies to optimize development. VaccinesEndeavoring to deliver potentially superior and novel vaccines, beginning with its lead program: A broad-spectrum pneumococcal conjugate vaccine. Well-FinancedBacked by a world-class syndicate of private equity, venture capital, institutional & corporate venture investors. Change the Shape of Vaccine Research. Join Our Team.     View Open Positions Copyright © 2022 Vaxcyte, Inc. All Rights Reserved. Close MenuAbout UsCorporate ProfileManagement TeamBoard of DirectorsScientific Advisory BoardOur PlatformOur ProgramsConjugate VaccinesLead Program: PCVPipelinePosters / PublicationsInvestors & MediaOverviewPress ReleasesEvents & PresentationsCorporate GovernanceGovernance OverviewBoard of DirectorsManagementCommittee CompositionFinancials & FilingsStock InformationStock Quote & ChartHistoric Price LookupAnalyst CoverageInvestor ResourcesInvestor FAQsEmail AlertsIR ContactTax DisclosuresCareersContact !function(t,e){"object"==typeof exports&&"undefined"!=typeof module?module.exports=e():"function"==typeof define&&define.amd?define(e):(t="undefined"!=typeof globalThis?globalThis:t||self).LazyLoad=e()}(this,function(){"use strict";function e(){return(e=Object.assign||function(t){for(var e=1;e